What is Scispot?
Scispot is a Canadian-headquartered company that provides the AI-native operating layer for self-driving laboratories. It empowers teams in biotech, diagnostics, pharma, CRO/CDMO, bioproduction, and biobanking to coordinate lab execution in real-time. By replacing manual handoffs with connected, traceable operations, Scispot enables life sciences teams to manage experiments, samples, results review, and report generation with enhanced efficiency and reduced manual coordination. The company's platform integrates instruments, samples, workflows, approvals, data, and AI agents to streamline complex laboratory processes.
How much funding has Scispot raised?
Scispot has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2026): $8M with participation from Avenue Growth Partners
Key Investors in Scispot
Avenue Growth Partners
Avenue Growth Partners is a venture capital firm that specializes in providing early growth equity to businesses, with a focus on vertical-specific investments. They aim to partner with companies to unlock their potential and achieve significant growth, targeting a 4x increase in business value within 3-5 years. Their team possesses expertise in technology and AI innovation, making them a strategic backer for companies like Scispot.
What's next for Scispot?
With its latest major enterprise-level funding, Scispot is poised for significant expansion and further development of its AI-native operating layer. This strategic investment will likely fuel advancements in its platform capabilities, enabling broader adoption within the life sciences industry. The company's focus on coordinating lab execution as work happens positions it to capitalize on the growing demand for automated and data-driven laboratory solutions, driving innovation in drug discovery, diagnostics, and biomanufacturing.
See full Scispot company page
